Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Prostate Cryotherapy

  • Chapter
  • First Online:
Management of Prostate Cancer

Abstract

Cryotherapy is a recognized treatment option for prostate cancer both in the primary and salvage settings. Herein, we summarize the current knowledge on cryotherapy for prostate cancer including elements of cryobiology, complications, oncological, and functional outcomes of primary and salvage cryoablation of the prostate. Cryotherapy in the primary setting appears to have a low morbidity profile, apart from erectile dysfunction, with most complications being transient and self-limiting. In the salvage setting, the rates of some adverse events are higher than in the primary setting but compare favorably with alternative salvage treatments. Biochemical disease-free outcomes remain challenging to summarize for both primary and salvage cryoablation due to widespread variability in the patient selection and recurrence criterion used. However, as long term outcomes (cancer-specific, metastasis-free, and overall survival) begin to mature, promising results emerge in carefully selected patients. Further work remains to be done in refining candidate selection criteria and defining long term oncological and functional outcomes. Cryotherapy for prostate cancer is an established technique, supported by favorable results, but in need of further high quality data.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arnott J. Practical illustrations of the remedial efficacy of a very low or anaesthetic temperature.-I. In Cancer. Lancet. 1850;56(1411):316–8.

    Article  Google Scholar 

  2. Babaian RJ, Donnely B, Bahn D, Baust JG, Dineen M, Ellis D, et al. Best practice policy statement on cryosurgery for the treatment of localized prostate cancer. AUA Clinical Guidelines [Internet]. 2008 2/8/2010. Available from: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm.

  3. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124–37.

    Article  PubMed  Google Scholar 

  4. Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology. 2014;68(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  5. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;247(3 Pt 1):C125–42.

    CAS  PubMed  Google Scholar 

  6. Theodorescu D. Cryotherapy for prostate cancer: what we know, what we need to know. J Urol. 2008;180(2):437–8.

    Article  PubMed  Google Scholar 

  7. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.

    Article  PubMed  Google Scholar 

  8. Robilotto AT, Baust JM, Van Buskirk RG, Gage AA, Baust JG. Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer model. Prostate Cancer Prostatic Dis. 2013;16(1):41–9.

    Article  CAS  PubMed  Google Scholar 

  9. Clarke DM, Robilotto AT, VanBuskirk RG, Baust JG, Gage AA, Baust JM. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2007;10(2):175–84.

    Article  CAS  PubMed  Google Scholar 

  10. Kimura M, Rabbani Z, Mouraviev V, Tsivian M, Caso J, Satoh T, et al. Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study. Urology. 2010;76(3):764 e14–20.

    Article  Google Scholar 

  11. Santucci KL, Snyder KK, Baust JM, Van Buskirk RG, Mouraviev V, Polascik TJ, et al. Use of 1,25alpha dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model. Prostate Cancer Prostatic Dis. 2011;14(2):97–104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ablin RJ. Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology. 1974;11(5):416–22.

    Article  CAS  PubMed  Google Scholar 

  13. Urano M, Tanaka C, Sugiyama Y, Miya K, Saji S. Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model. Cryobiology. 2003;46(3):238–45.

    Article  CAS  PubMed  Google Scholar 

  14. Udagawa M, Kudo-Saito C, Hasegawa G, Yano K, Yamamoto A, Yaguchi M, et al. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation. Clin Cancer Res. 2006;12(24):7465–75.

    Article  CAS  PubMed  Google Scholar 

  15. Yamashita T, Hayakawa K, Hosokawa M, Kodama T, Inoue N, Tomita K, et al. Enhanced tumor metastases in rats following cryosurgery of primary tumor. Gann. 1982;73(2):222–8.

    CAS  PubMed  Google Scholar 

  16. Miya K, Saji S, Morita T, Niwa H, Sakata K. Experimental study on mechanism of absorption of cryonecrotized tumor antigens. Cryobiology. 1987;24(2):135–9.

    Article  CAS  PubMed  Google Scholar 

  17. Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  18. Gage AA, Baust JG. Cryosurgery for tumors. J Am Coll Surg. 2007;205(2):342–56.

    Article  PubMed  Google Scholar 

  19. Klossner DP, Robilotto AT, Clarke DM, VanBuskirk RG, Baust JM, Gage AA, et al. Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems. Cryobiology. 2007;55(3):189–99.

    Article  PubMed  Google Scholar 

  20. Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48(3):441–7.

    Article  CAS  PubMed  Google Scholar 

  21. Gage AA, Baust JM, Baust JG. Experimental cryosurgery investigations in vivo. Cryobiology. 2009;59(3):229–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37(3):171–86.

    Article  CAS  PubMed  Google Scholar 

  23. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59(1):61–71.

    Article  PubMed  Google Scholar 

  24. Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int. 2010;105(2):191–201.

    Article  CAS  PubMed  Google Scholar 

  25. Ng CK, Moussa M, Downey DB, Chin JL. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol. 2007;178(4 Pt 1):1253–7; discussion 7.

    Article  PubMed  Google Scholar 

  26. Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer. 2006;107(2):275–80.

    Article  CAS  PubMed  Google Scholar 

  27. Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007;100(4):760–4.

    Article  PubMed  Google Scholar 

  28. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2 Suppl 1):3–11.

    Article  PubMed  Google Scholar 

  29. Shinohara K, Connolly JA, Presti Jr JC, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996;156(1):115–20; discussion 20–1.

    Article  CAS  PubMed  Google Scholar 

  30. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170(4 Pt 1):1126–30.

    Article  PubMed  Google Scholar 

  31. Wake RW, Hollabaugh Jr RS, Bond KH. Cryosurgical ablation of the prostate for localized adenocarcinoma: a preliminary experience. J Urol. 1996;155(5):1663–6.

    Article  CAS  PubMed  Google Scholar 

  32. DiBlasio CJ, Derweesh IH, Malcolm JB, Maddox MM, Aleman MA, Wake RW. Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer. Int Braz J Urol. 2008;34(4):443–50.

    Article  PubMed  Google Scholar 

  33. Cohen JK. Cryosurgery of the prostate: techniques and indications. Rev Urol. 2004;6 Suppl 4:S20–6.

    PubMed  PubMed Central  Google Scholar 

  34. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer. 2005;103(8):1625–30.

    Article  PubMed  Google Scholar 

  35. Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. J Endourol. 2007;21(12):1521–31.

    Article  PubMed  Google Scholar 

  36. Donnelly BJ, Saliken JC, Brasher PM, Ernst SD, Rewcastle JC, Lau H, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 2010;116(2):323–30.

    Article  CAS  PubMed  Google Scholar 

  37. Chin JL, Ng CK, Touma NJ, Pus NJ, Hardie R, Abdelhady M, et al. Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis. 2008;11(1):40–5.

    Article  CAS  PubMed  Google Scholar 

  38. Lian H, Guo H, Gan W, Li X, Yan X, Wang W, et al. Cryosurgery as primary treatment for localized prostate cancer. Int Urol Nephrol. 2011.

    Google Scholar 

  39. Caso JR, Tsivian M, Mouraviev V, Kimura M, Polascik TJ. Complications and postoperative events after cryosurgery for prostate cancer. BJU Int. 2012;109(6):840–5.

    Article  PubMed  Google Scholar 

  40. Rodriguez SA, Arias Funez F, Bueno Bravo C, Rodriguez-Patron Rodriguez R, Sanz Mayayo E, Palacios VH, et al. Cryotherapy for primary treatment of prostate cancer: intermediate term results of a prospective study from a single institution. Prostate Cancer. 2014;2014:571576.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Ward JF, DiBlasio CJ, Williams C, Given R, Jones JS. Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry. BJU Int. 2014;113(5):714–8.

    Article  PubMed  Google Scholar 

  42. Ghafar MA, Johnson CW, De La Taille A, Benson MC, Bagiella E, Fatal M, et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001;166(4):1333–7; discussion 7–8.

    Article  CAS  PubMed  Google Scholar 

  43. Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol. 2007;178(2):529–34; discussion 34.

    Article  PubMed  Google Scholar 

  44. Roberts CB, Jang TL, Shao YH, Kabadi S, Moore DF, Lu-Yao GL. Treatment profile and complications associated with cryotherapy for localized prostate cancer: a population-based study. Prostate Cancer Prostatic Dis. 2011.

    Google Scholar 

  45. Kimura M, Mouraviev V, Tsivian M, Moreira DM, Mayes JM, Polascik TJ. Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation. Urology. 2010;76(5):1258–65.

    Article  PubMed  Google Scholar 

  46. Malcolm JB, Fabrizio MD, Barone BB, Given RW, Lance RS, Lynch DF, et al. Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J Urol. 2010;183(5):1822–8.

    Article  PubMed  Google Scholar 

  47. Kimura M, Donatucci CF, Tsivian M, Caso JR, Moreira DM, Mouraviev V, et al. On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation. Int J Impot Res. 2011;23(2):49–55.

    Article  CAS  PubMed  Google Scholar 

  48. Ellis DS, Manny Jr TB, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007;69(2):306–10.

    Article  PubMed  Google Scholar 

  49. Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int. 2004;93(1):14–8.

    Article  PubMed  Google Scholar 

  50. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180(2):559–63; discussion 63–4.

    Article  PubMed  Google Scholar 

  51. Cresswell J, Asterling S, Chaudhary M, Sheikh N, Greene D. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int. 2006;97(5):969–74.

    Article  PubMed  Google Scholar 

  52. Bahn DK, Lee F, Silverman P, Bahn E, Badalament R, Kumar A, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2(2):111–4.

    Article  PubMed  Google Scholar 

  53. Kvorning Ternov K, Krag Jakobsen A, Bratt O, Ahlgren G. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer. Scand J Urol. 2015;49(2):115–9.

    Article  CAS  PubMed  Google Scholar 

  54. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180(2):554–8.

    Article  PubMed  Google Scholar 

  55. Chin JL, Al-Zahrani AA, Autran-Gomez AM, Williams AK, Bauman G. Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b). J Urol. 2012;188(4):1170–5.

    Article  PubMed  Google Scholar 

  56. Guo Z, Si T, Yang X, Xu Y. Oncological outcomes of cryosurgery as primary treatment in T3 prostate cancer: experience of a single centre. BJU Int. 2015;116(1):79–84.

    Article  PubMed  Google Scholar 

  57. Tay KJ, Polascik TJ, Elshafei A, Cher ML, Given RW, Mouraviev V, et al. Primary cryotherapy for high-grade clinically localized prostate cancer: oncologic and functional outcomes from the COLD registry. J Endourol. 2016;30(1):43–8.

    Article  PubMed  Google Scholar 

  58. Levy DA, Ross AE, ElShafei A, Krishnan N, Hatem A, Jones JS. Definition of biochemical success following primary whole gland prostate cryoablation. J Urol. 2014;192(5):1380–4.

    Article  CAS  PubMed  Google Scholar 

  59. Cohen JK, Miller Jr RJ, Ahmed S, Lotz MJ, Baust J. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology. 2008;71(3):515–8.

    Article  PubMed  Google Scholar 

  60. Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz A. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol/Endourol Soc. 2010;24(7):1123–9.

    Article  Google Scholar 

  61. Elshafei A, Kovac E, Dhar N, Levy D, Polascik T, Mouraviev V, et al. A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate. Prostate. 2015;75(13):1447–53.

    Article  CAS  PubMed  Google Scholar 

  62. Caso JR, Tsivian M, Mouraviev V, Polascik TJ. Predicting biopsy-proven prostate cancer recurrence following cryosurgery. Urol Oncol. 2010.

    Google Scholar 

  63. Williams AK, Martinez CH, Lu C, Ng CK, Pautler SE, Chin JL. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol. 2011;60(3):405–10.

    Article  PubMed  Google Scholar 

  64. de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, et al. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int. 2013;112(3):298–307.

    Article  PubMed  Google Scholar 

  65. Williams AK, Martinez CH, Lu C, Ng CK, Pautler SE, Chin JL. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol. 2010;60:405.

    Article  PubMed  Google Scholar 

  66. Levy DA, Pisters LL, Jones JS. Prognostic value of initial prostate-specific antigen levels after salvage cryoablation for prostate cancer. BJU Int. 2010;106(7):986–90.

    Article  PubMed  Google Scholar 

  67. Kovac E, Elshafei A, Tay KJ, Mendez MH, Polascik T, Jones JS. 5-Year biochemical progression-free survival following salvage whole-gland prostate cryoablation: defining success with nadir PSA. J Endourol. 2016.

    Google Scholar 

  68. Levy DA, Li J, Jones JS. Disease burden predicts for favorable post salvage cryoablation PSA. Urology. 2010;76(5):1157–61.

    Article  PubMed  Google Scholar 

  69. Spiess PE, Katz AE, Chin JL, Bahn D, Cohen JK, Shinohara K, et al. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int. 2010;106(2):194–8.

    Article  PubMed  Google Scholar 

  70. Polascik TJ, Mouraviev V. Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients. Urology. 2009;74(4):726–30.

    Article  PubMed  Google Scholar 

  71. Polascik TJ, Mayes JM, Mouraviev V. Nerve-sparing focal cryoablation of prostate cancer. Curr Opin Urol. 2009;19(2):182–7.

    Article  PubMed  Google Scholar 

  72. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605–13.

    Article  PubMed  Google Scholar 

  73. Bahn D, de Castro Abreu AL, Gill IS, Hung AJ, Silverman P, Gross ME, et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol. 2012;62(1):55–63.

    Article  PubMed  Google Scholar 

  74. Barqawi AB, Stoimenova D, Krughoff K, Eid K, O’Donnell C, Phillips JM, et al. Targeted focal therapy for the management of organ confined prostate cancer. J Urol. 2014;192(3):749–53.

    Article  PubMed  Google Scholar 

  75. Durand M, Barret E, Galiano M, Rozet F, Sanchez-Salas R, Ahallal Y, et al. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. BJU Int. 2014;113(1):56–64.

    Article  PubMed  Google Scholar 

  76. Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Eur J Cancer Care. 2007;70(6 Suppl):9–15.

    Google Scholar 

  77. Hale Z, Miyake M, Palacios DA, Rosser CJ. Focal cryosurgical ablation of the prostate: a single institute’s perspective. BMC Urol. 2013;13:2.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Lian H, Zhuang J, Yang R, Qu F, Wang W, Lin T, et al. Focal cryoablation for unilateral low-intermediate-risk prostate cancer: 63-month mean follow-up results of 41 patients. Int Urol Nephrol. 2015.

    Google Scholar 

  79. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.

    Article  PubMed  Google Scholar 

  80. Truesdale MD, Cheetham PJ, Hruby GW, Wenske S, Conforto AK, Cooper AB, et al. An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up. Cancer J (Sudbury, Mass). 2010;16(5):544–9.

    Article  Google Scholar 

  81. Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int. 2012;109(11):1648–54.

    Article  PubMed  Google Scholar 

  82. Li YH, Elshafei A, Agarwal G, Ruckle H, Powsang J, Jones JS. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. Prostate. 2015;75(1):1–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC, USA

    Kae Jack Tay, Matvey Tsivian & Thomas J. Polascik MD, FACS

Authors
  1. Kae Jack Tay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matvey Tsivian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas J. Polascik MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas J. Polascik MD, FACS .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Hôpital Albert Michallon, Grenoble, France

    Michel Bolla

  2. Department of Urology, University Hospitals Leuven, Leuven, Belgium

    Hendrik van Poppel

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Tay, K.J., Tsivian, M., Polascik, T.J. (2017). Prostate Cryotherapy. In: Bolla, M., van Poppel, H. (eds) Management of Prostate Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-42769-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42769-0_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42768-3

  • Online ISBN: 978-3-319-42769-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation